TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 24 filers reported holding TRILLIUM THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $2,811,000 | -30.5% | 160,062 | -61.6% | 0.01% | -33.3% |
Q2 2021 | $4,044,000 | -5.1% | 416,924 | +5.0% | 0.02% | -10.0% |
Q1 2021 | $4,263,000 | +1084.2% | 396,945 | +1521.4% | 0.02% | +900.0% |
Q4 2020 | $360,000 | +146.6% | 24,482 | -88.9% | 0.00% | +100.0% |
Q1 2019 | $146,000 | – | 220,564 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NEA Management Company, LLC | 2,100,000 | $646,000 | 0.05% |
Matrix Capital Management Company, LP | 2,288,560 | $704,000 | 0.02% |
Tekla Capital Management LLC | 446,099 | $137,000 | 0.01% |
Realta Investment Advisors | 26,000 | $7,000 | 0.00% |
Virtu Financial LLC | 34,991 | $11,000 | 0.00% |
Baker Brothers Advisors | 505,262 | $155,000 | 0.00% |
BOOTHBAY FUND MANAGEMENT, LLC | 20,044 | $6,000 | 0.00% |
MORGAN STANLEY | 1,160,098 | $356,000 | 0.00% |
BANK OF MONTREAL /CAN/ | 18,333 | $6,000 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 102,725 | $31,000 | 0.00% |